Emergent BioSolutions Inc. revised earnings guidance for the year 2020. For the year, the company expects total revenues in the range of $1,545 million - $1,555 million against the previous guidance of $1,520 million - $1,580 million, net income in the range of $295 million - $310 million against the previous guidance of $255 million - $285 million.